معرفی
Olivier Terrier is a Researcher at the International Center for Research in Infectiology (CIRI) in Lyon. He holds a PhD in Virology from the University of Lyon 1 (2008). His research focuses on viral infections such as influenza, parainfluenza, respiratory syncytial virus (RSV), and SARS-CoV-2, with emphasis on antiviral drug development, host-virus interactions, and respiratory pathogenesis.
Research Interests:
- Host-pathogen interactions in respiratory epithelia
- Antiviral drug combinations and repurposing
- Viral-bacterial coinfections and their clinical implications
- Mechanisms of SARS-CoV-2 pathogenesis
Recent Work Trends (2021–2025):
Recent studies explore SARS-CoV-2 responses in respiratory diseases, synergistic antiviral drug effects, and predictive models for severe outcomes in hospitalized patients. His work integrates in vitro cellular models and in vivo animal studies to evaluate vaccine candidates and therapeutic strategies.
Advising & Collaborations:
- Co-advisor on viral pathogenesis projects with collaborators like Dr. Saw-See Hong and Prof. Andrés Pizzorno
- Led over 70 peer-reviewed publications, including high-impact journals like Science Immunology and Nature Communications
Labs & Teams:
He leads the VirPath team at CIRI, focusing on viral respiratory infections and translational research in antiviral therapies.
